MENU

Niosomes as a bilayer nanocarrier for combinative drug delivery

Presented at: Bioprocessing 2021
C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

The past few decades have seen a substantial increase in the research based on nanocarrier based combinative drug therapies in various diseases such as cancer, tuberculosis, Alzheimer’s and, asthma. However, due to prolonged dosage regimens, increased doses of the drugs, side effects and lack of stability, their large-scale use and upscaling to industrial levels have been affected. Hence, there is a need to develop a nano drug delivery approach in order to tackle the above issues and provide a better therapy to the patients. Niosomes or non-ionic surfactant-based liposomes are promising bilayer nanocarriers with an ability to entrap drugs having different modes of action within a single vesicle. There have been many potential advancements in this specific field where lipid based nanocarriers have showcased excellent stability of the nanoformulation along with better therapeutic actions in comparison to free drug combinations.  This talk will specifically focus on the use and future potential of these bilayer niosomes as a combinative drug delivery option for future treatments. This presentation will also showcase our work on the use of dual drug loaded niosomes in regards to the treatment of Tuberculosis and Breast cancer.

Learning Objectives:

1. Provide budding researchers and students to come up with novel combinatorial drug delivery approaches using different lipidic and other nanocarriers.

2. Showcase the potential of niosomes as a robust alternative to liposomes in terms of drug effectiveness and stability.

3. Using this approach or technology targeting different diseases using FDA approved drugs and nanocarriers is envisioned for a faster clinical trial and market approval of the nanoformulation.

4. The study discussed will help in fostering novel ideas and applications in different areas of pharmaceutical and medical sciences.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
Loading Comments...
Show Resources